by Inventeur, LLC.

AIM - Direct Pharyngeal Oxygenation

AIM is an intraoral bite block with pharyngeal oxygen delivery and continous capnography for procedures requiring sedation.

AIM Anesthesia Intraoral Module - Direct Pharyngeal Oxygenation Device

The problem with oxygen delivery during sedation

Non-operating room anesthesia (NORA) is the fastest-growing segment in anesthesia, but oxygen delivery and patient monitoring haven't kept pace with the increasingly complex procedures and higher-risk patients.

Nasal cannulas

Limited FiO2 control. Unreliable CO2 monitoring in patients with oral breathing, most common while sedated.

Face masks

Max FiO2 around 60%. Masks block airway rescue access and interfere with endoscopy and oropharyngeal procedures.

High Flow Nasal Cannula

Specialized high-flow O2 equipment increases cost, complexity, and fire risk. Very limited capnography.

AIM solves this.

A single intraoral device that delivers direct pharyngeal oxygenation with integrated CO2 sampling from pre-sedation through recovery.

  • >96% FiO2 comparable to high-flow nasal cannulas at a fraction of the cost and complexity
  • No-gag design allows oxygenation before sedation and in recovery
  • Reliable end-tidal CO2 waveform for continuous monitoring
  • Oral cavity access for airway rescue and EGD/TEE scope placement
  • Designed for high-risk, ASA III and IV patients
  • MRI Safe — cleared for use in MRI suite environments

What clinicians are saying

M. Zales, MD

With oxygen delivery comparable to the high-flow cannula, but at a fraction of the cost and without the cumbersome setup, AIM is ideal for the NORA setting.

M. Blevins, CAA

I recently used AIM on a morbidly obese patient undergoing endoscopy. Despite the challenging body habitus, oxygen saturation stayed 100% throughout the procedure. The reliability in this high-risk setting was impressive and clinically reassuring.

B. DeBoard, CRNA

AIM gives me the confidence to perform high-risk sedation procedures.

Todd Little, CRNA

What impressed me the most about AIM was the speed in correcting oxygen saturation after apnea. Pharyngeal oxygenation really works. This device could be a game-changer.

K. Byju, MD, Gastroenterologist

With unobtrusive access to the oral cavity, scope placement was easier. AIM prevented hypoxic episodes without any procedural interruptions.

FDA

510(k) Cleared

AIM is an FDA-cleared Class II medical device. Designed, developed, and manufactured in the United States.

With continuous EtCO2 monitoring, AIM meets the ASA sedation guidelines

How AIM compares

As procedural complexity and patient acuity increase, AIM occupies the sweet spot: higher performance than nasal cannula, lower cost than HFNC, more versatile than face mask.

AIM HFNC Nasal Cannula Face Mask
FiO2 Delivered >96% at 14LPM 100% at 70LPM 30-40% 50-60%
Continuous EtCO2 Yes Unreliable Yes Yes
Immediate Oral Access Yes No No Blocked
Integrated Bite Block Yes No No No
Setup Time <1 min ~5 min <1 min <1 min
MRI Safe Yes No Yes Yes
ASA Guideline Compliance Full Partial Yes Yes
O2 Equipment Required Standard Specialized Standard Standard
Immediate GA Conversion Yes No No No
Fire Risk Low High Medium Medium
Staff Training Minimal Moderate Minimal Minimal
Space Requirements Minimal Significant Minimal Minimal
Maintenance None (disposable) Regular servicing None None
Patient Comfort High Moderate High Low
Cost per Procedure $$$ $$$$$ $$ $$

How it works

1

Connect

Attach the oxygen supply line and CO2 sampling line to your existing equipment.

2

Place

Insert the AIM bite block intraorally, just like a standard bite block.

3

Monitor

Deliver oxygen and monitor capnography throughout the procedure with unobstructed airway access.

See it in action

Watch Dr. Zales demonstrate AIM setup and use.

Designed for today's procedural sedation environments

GI / Endoscopy Suites

Maintain oxygenation and monitoring during upper and lower endoscopy procedures.

Cath Labs

Reliable oxygen delivery during cardiac catheterization and electrophysiology procedures.

Interventional Radiology

Continuous monitoring during image-guided biopsies and procedures under sedation.

Dental / Oral Surgery

Integrated bite block with oxygen delivery for dental procedures requiring sedation.

MRI Suite

MRI Safe construction allows AIM to be used in MRI suite environments for sedated scans and interventional MRI procedures.

Chronic Pain Procedures

Consistent oxygenation and capnography across nerve blocks, spinal injections, kyphoplasty, and spinal cord stimulator implants.

Minor GYN Procedures

Supports sedation monitoring during hysteroscopy, endometrial ablation, and D&C in ASC and office-based settings.

Image-Guided Biopsies

Reliable pharyngeal oxygenation and CO2 monitoring during IR-guided breast, tissue, and bone biopsy procedures under sedation.

The economic case for integrated airway management

NORA case volume is growing faster than any other procedural category. Every minute of airway-related interruption carries a real cost -- in time, disposables, and throughput. AIM was designed to reduce all three.

Fewer interruptions, faster cases

Continuous oropharyngeal oxygen delivery reduces desaturation events that force procedural pauses. Integrated capnography eliminates separate monitoring setup. Fewer device exchanges mean fewer workflow disruptions.

One device replaces several

AIM integrates the functions of a bite block, supplemental oxygen delivery system, and capnography sampling interface into a single disposable. Fewer SKUs to order, stock, and manage.

More cases, same schedule

When per-case airway setup and management time decreases -- even by minutes -- the cumulative effect across a full procedural day enables tighter scheduling and improved room utilization.

A simple framework to estimate your economic benefit

Published data estimates OR time costs at $45-60 per minute.* NORA suite costs vary by facility but follow similar economic drivers. Consider your own numbers:

Cases per week How many NORA cases does your facility perform weekly?
Minutes saved per case If AIM eliminates even 2-3 minutes of interruption or setup time, what is the weekly total?
Disposables replaced How many separate items (bite block, nasal cannula, capnography adapter) does AIM consolidate?
Cost per disposable set What is your current per-case spend on those individual components?

We encourage you to run these numbers for your facility. For a detailed analysis tailored to your case volume, contact our team.

*Macario A. "What does one minute of operating room time cost?" J Clin Anesth. 2010;22(4):233-236. Inflation-adjusted.

Frequently asked questions

Common questions from clinicians and facilities evaluating AIM.

How is AIM different from a standard nasal cannula and bite block?

The standard nasal cannula and separate bite block delivers oxygen to the nose only, or at most also to the front of the mouth in specialty systems. Oral breathing is more common when a patient is sedated, so nasal delivery has limited FiO2 potential. Any oxygen delivered to the front of the mouth is diluted and is also limited. AIM delivers oxygen directly to the posterior pharynx from inside the mouth so FiO2 saturation can be maintained. AIM delivered greater than 96% FiO2 at 14 LPM while simultaneously providing reliable end-tidal CO2 waveforms through an integrated sampling port.

What does direct pharyngeal oxygenation mean clinically?

Direct pharyngeal oxygenation means oxygen is delivered from inside the oral cavity to the posterior pharynx, the anatomical space immediately above the airway opening. This enables standard oxygen flow to deliver very high FiO2 levels because it is not diluted in the mouth or nasal cavity. Mouth breathing is most common in sedated patients, so nasal delivery can be unreliable and limit maximum FiO2. Pharyngeal delivery overcomes this limitation and is particularly effective in obese patients, oral breathers, and cases where nasal airflow is compromised.

What training is required to use AIM?

The beauty of AIM is in its simplicity! AIM is placed and connected in under one minute by any trained anesthesia provider. The workflow mirrors a standard bite block: connect the oxygen supply and CO2 sampling lines, then insert intraorally. See the IFU for full details.

What clinical evidence supports AIM's effectiveness?

AIM is FDA-cleared through the 510(k) pathway as a Class II medical device. Clinical experience includes reported SpO2 maintenance at 100% in morbidly obese patients, reliable EtCO2 waveforms across GI and cardiac procedural settings, and no procedural interference during endoscopy. Peer-reviewed publications are in progress. Contact us for our current clinical data package. [VERIFY: add any published abstracts, posters, or journal references if available]

More questions? View the full FAQ or contact our team.

Our team

Built by anesthesiologists and engineers with deep experience in clinical practice and medical device development.

Tariq Chaudhry, MD

Inventor & Founder, Inventeur LLC
Practicing Anesthesiologist

Roman Schumann, MD

Professor of Anesthesiology

Juan Valdivia, MD

Neurosurgeon

Raymond Vennare

CEO, Inventeur LLC

Andrew McCutchen

Engineer
President & CEO, Baymar Solutions

Matthew Petney

Engineer, Product Manager
VP of Engineering, Baymar Solutions

Get in touch

Request a sample, schedule a demo, or ask us anything.

Or email us directly at info@macmodule.com

Purchase through authorized distributors

AIM is available through the following authorized distribution partners.

MarketLab

Authorized Distributor

1-800-237-3722

Alamo Technologies

Authorized Distributor

1-201-793-8941